About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

18F-AV-1451 High Resolution Autopsy Study | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 1NCT02350634

18F-AV-1451 High Resolution Autopsy Study

The study is designed to examine the relationship between imaging results detected on a 18F-AV-1451 PET scan and pathology found at autopsy within six months of imaging.

Lead sponsor: Avid Radiopharmaceuticals•2 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Avid Radiopharmaceuticals

Age

60 - 89 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Projected life expectancy ≤ 6 months

Exclusion Criteria

•Primary brain tumor, known metastases to the brain, central nervous system lymphoma
•Major, focal structural brain lesion
•Aggressively being treated with life sustaining measures
•Clinically significant infectious disease
•History of risk factors for Torsades de Pointes or are currently taking medication known to cause QT prolongation
•Have received or participated in a trial with investigational medications in the past 30 days
•Females of childbearing potential who are pregnant or not using adequate contraception

Related studies

Blood-based Biomarkers for Alzheimer's Disease at the Primary Care Level.

NCT07666113 · Alzheimer's Disease (AD)

RECRUITINGPhase 1

A Study to Evaluate ALN-5288 in Patients With Alzheimer's Disease

NCT07214727 · Alzheimer's Disease

RECRUITINGPhase 2

A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease Patients

NCT06745583 · Mild, Moderate, or Severe Alzheimer's Disease

Mindfulness to Enhance Cognitive Health in Latino Older Adults

NCT07040904 · Mindfulness, Alzheimer's Disease Related Dementia

δ in Dementia Clinical Trials

NCT05592678 · Alzheimer's Disease (AD), Dementia, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 10, 2025Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1

Enrollment3

Start dateNov 2016

Last updatedJun 10, 2025

Condition

Alzheimer's Disease

Locations shown

Banner Alzheimer's Institute

Phoenix, Arizona

University of California, San Francisco

San Francisco, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 10, 2025Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions